These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19366333)

  • 1. A randomized controlled clinical trial of the use of benazepril and heparin for the treatment of chronic kidney disease in dogs.
    Tenhündfeld J; Wefstaedt P; Nolte IJ
    J Am Vet Med Assoc; 2009 Apr; 234(8):1031-7. PubMed ID: 19366333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effects of a therapeutic renal diet to control proteinuria in proteinuric non-azotemic dogs treated with benazepril.
    Cortadellas O; Talavera J; Fernández del Palacio MJ
    J Vet Intern Med; 2014; 28(1):30-7. PubMed ID: 24372810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Benazepril on Survival of Dogs with Chronic Kidney Disease: A Multicenter, Randomized, Blinded, Placebo-Controlled Clinical Trial.
    King JN; Font A; Rousselot JF; Ash RA; Bonfanti U; Brovida C; Crowe ID; Lanore D; Pechereau D; Seewald W; Strehlau G
    J Vet Intern Med; 2017 Jul; 31(4):1113-1122. PubMed ID: 28669137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of an angiotensin-converting enzyme inhibitor, benazepril, and its active metabolite, benazeprilat, after repeated administrations of benazepril in dogs with experimental kidney impairment.
    Kitagawa H; Eguchi T; Kitoh K; Ohba Y; Kondo M; Nakano M; Sasaki Y
    J Vet Med Sci; 2000 Feb; 62(2):179-85. PubMed ID: 10720188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and efficacy of benazepril in cats with chronic kidney disease.
    King JN; Gunn-Moore DA; Tasker S; Gleadhill A; Strehlau G;
    J Vet Intern Med; 2006; 20(5):1054-64. PubMed ID: 17063696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of benazepril for advanced chronic renal insufficiency.
    Hou FF; Zhang X; Zhang GH; Xie D; Chen PY; Zhang WR; Jiang JP; Liang M; Wang GB; Liu ZR; Geng RW
    N Engl J Med; 2006 Jan; 354(2):131-40. PubMed ID: 16407508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Can angiotensin-converting enzyme inhibitor be used in chronic kidney disease patients with serum creatinine level greater than 266 micromol/L?].
    Zhang GH; Hou FF; Zhang X; Liu QF
    Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):592-6. PubMed ID: 16194413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
    Bakris GL; Sarafidis PA; Weir MR; Dahlöf B; Pitt B; Jamerson K; Velazquez EJ; Staikos-Byrne L; Kelly RY; Shi V; Chiang YT; Weber MA;
    Lancet; 2010 Apr; 375(9721):1173-81. PubMed ID: 20170948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the angiotensin converting enzyme inhibitor benazepril in cats with induced renal insufficiency.
    Brown SA; Brown CA; Jacobs G; Stiles J; Hendi RS; Wilson S
    Am J Vet Res; 2001 Mar; 62(3):375-83. PubMed ID: 11277203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.
    Maschio G; Alberti D; Janin G; Locatelli F; Mann JF; Motolese M; Ponticelli C; Ritz E; Zucchelli P
    N Engl J Med; 1996 Apr; 334(15):939-45. PubMed ID: 8596594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors and kidney protection: the AIPRI trial. The ACE Inhibition in Progressive Renal Insufficiency (AIPRI) Study Group.
    Maschio G; Alberti D; Locatelli F; Mann JF; Motolese M; Ponticelli C; Ritz E; Janin G; Zucchelli P
    J Cardiovasc Pharmacol; 1999; 33 Suppl 1():S16-20; discussion S41-3. PubMed ID: 10028949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label, randomized, controlled, 4-week comparative clinical trial of barnidipine hydrochloride, a calcium-channel blocker, and benazepril, an angiotensin-converting enzyme inhibitor, in Chinese patients with renal parenchymal hypertension.
    Chen X; Zheng F; Chen P; Tang L; Wei R; Yu Y; Su Y; Kikkawa T; Yamamoto M
    J Int Med Res; 2006; 34(2):121-8. PubMed ID: 16749407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of hypertension and effects of benazepril hydrochloride in a canine remnant kidney model of chronic renal failure.
    Mishina M; Watanabe T
    J Vet Med Sci; 2008 May; 70(5):455-60. PubMed ID: 18525166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long-term administration of enalapril on clinical indicators of renal function in dogs with compensated mitral regurgitation.
    Atkins CE; Brown WA; Coats JR; Crawford MA; DeFrancesco TC; Edwards J; Fox PR; Keene BW; Lehmkuhl L; Luethy M; Meurs K; Petrie JP; Pipers F; Rosenthal S; Sidley JA; Straus J
    J Am Vet Med Assoc; 2002 Sep; 221(5):654-8. PubMed ID: 12216903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the clinical efficacy of benazepril in the treatment of chronic renal insufficiency in cats.
    Mizutani H; Koyama H; Watanabe T; Kitagawa H; Nakano M; Kajiwara K; King JN
    J Vet Intern Med; 2006; 20(5):1074-9. PubMed ID: 17063698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a fixed-dose combination of benazepril and pimobendan in dogs with congestive heart failure: a randomized non-inferiority clinical trial.
    King JN; Hirakawa A; Sonobe J; Otaki H; Sakakibara N; Seewald W; Forster S
    J Vet Sci; 2018 Jan; 19(1):117-128. PubMed ID: 28693297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of renal impairment on the disposition of orally administered enalapril, benazepril, and their active metabolites.
    Lefebvre HP; Laroute V; Concordet D; Toutain PL
    J Vet Intern Med; 1999; 13(1):21-7. PubMed ID: 10052059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal actions of the new angiotensin-converting enzyme inhibitor benazepril hydrochloride.
    Levens NR
    Arch Int Pharmacodyn Ther; 1988; 296():131-43. PubMed ID: 2853611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Outcome of Irish Wolfhound Dogs with Preclinical Cardiomyopathy, Atrial Fibrillation, or Both Treated with Pimobendan, Benazepril Hydrochloride, or Methyldigoxin Monotherapy.
    Vollmar AC; Fox PR
    J Vet Intern Med; 2016; 30(2):553-9. PubMed ID: 26936799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.